1020 Kifer Rd
Sunnyvale, California 94086-5301
Phone: 14085232100
www.intuitivesurgical.com
William Blair launched its coverage on Intuitive Surgical (ISRG) with an Outperform rating on Thursday, while its shares have underperformed this year. Read the full story here.
https://www.investing.com/news/pro/william-blair-starts-intuitive-surgical-at-outperform-432SI-3037537
https://www.investing.com/news/pro/otr-global-reiterates-thumps-up-on-intuitive-surgical-432SI-3035777
Intuitive Surgical''s (NASDAQ: ISRG ) short percent of float has fallen 12.5% since its last report. The company recently reported that it has 2.21 million shares sold short , which is 0.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.2 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
The search for the top AI stock is on. Companies involved in artificial intelligence are at the forefront of a rapidly growing industry. Indeed, these companies are revolutionizing many sectors, including healthcare, finance, transportation, and manufacturing. Notably, since OpenAI introduced ChatGPT in late 2022, investors have taken on a renewed interest. AI is one of the fastest-growing industries, and the demand for AI products and services is expected to increase significantly in the coming years. AI has the potential to disrupt traditional industries and create new markets and opportunities for businesses that adopt it early. Additionally, AI stocks can help diversify an investor’s portfolio, reducing their overall risk exposure. Thus, there’s plenty of potential reasons to invest in the sector. Here are three of the best options in this space right now, in my view. MSFT Microsoft $255.29 ISRG Intuitive Surgical $234.87 RTX Raytheon $99.02 Microsoft (MSFT) Source: Peteri / Shutterstock.com Microsoft (NASDAQ: MSFT ) has invested heavily in research and development when it comes to artificial intelligence.
Intuitive Surgical (NASDAQ: ISRG ) has outperformed the market over the past 5 years by 29.05% on an annualized basis producing an average annual return of 36.67%. Currently, Intuitive Surgical has a market capitalization of $79.18 billion. Buying $100 In ISRG: If … Full story available on Benzinga.com
When it comes to the world of robotic surgery, there’s one company that stands head and shoulders above the rest — Intuitive Surgical (NYSE:ISRG). …
With many investors looking for ways to capitalize on the potential of AI stocks , this article will look at some of the hottest opportunities out there. After all, the global AI market, worth $119.78 billion in 2022, is forecast to skyrocket to $1,597.1 billion by 2030, with an impressive CAGR of 38.1% over the same period, according to Precedence Research. Better, the AI stocks on this list are trading at a fraction of their highs. ISRG Intuitive Surgical $233.55 WDAY Workday $184.37 GOOG GOOGL Alphabet $91.80 Intuitive Surgical (ISRG) Source: Shutterstock Founded in 1995, Intuitive Surgical (NASDAQ: ISRG ) has become one of the leading providers of robotic-assisted surgical systems, instruments, and accessories. Its products are used in various procedures, including gynecological, urological, general, colorectal, and head and neck surgeries. Intuitive Surgical aims to make surgery less invasive and improve patient outcomes. Along the way, the company has developed technologies such as the da Vinci Surgical System, allowing surgeons to perform complex procedures with greater precision and control.
Related Stocks: ISRG , XOM , ADSK , NVDA , AMD ,
Related Stocks: BMRN , CI , PLD , ISRG , PG ,
Intuitive is revolutionizing minimally invasive care through its range of products and services. Click here to read more about ISRG.
Intuitive Surgical reported Q4 and FY2022 results that fell below expectations. Click here to see why ISRG stock is a Hold.
Is this stock the next Intuitive Surgical? Maybe. We won''t know for sure, though, until it has something to sell.
RiverPark Advisors, an investment advisory firm, and sponsor of the RiverPark family of mutual funds released its “RiverPark Large Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned 2.41% in the fourth quarter compared to a 7.56% return for the S&P 500 Total Return Index and […]
Related Stocks: NVO , ISRG , SNPS , INTU , SIVB ,
Should you buy Intuitive Surgical despite the headwinds it''s facing right now?
The robotic surgery company is having a rough start to 2023.
Although the will-it-or-won’t-it debate regarding the probabilities of the economy falling into recession dominates business headlines, investors may still want to look ahead with breakthrough technology stocks to buy. These enterprises undergird some of the most groundbreaking innovations of our time, facilitating potentially permanent relevance. Fundamentally, technology stocks to buy benefit from the natural forward progress of human societies. After all, whether a recession materializes or not, enterprises will continue striving for bigger and better. In some ways, then, specific tech plays may be safer than you might initially believe. On the technical front, several breakthrough technology stocks to buy incurred steep losses last year. While red ink presents near-term challenges, over the long haul, acquiring deflated tech plays now could yield tremendous gains later. If you’re willing to ride out some turbulence, below are some of the best innovative companies available. ASML ASML $690.85 NVDA Nvidia $214.86 MSFT Microsoft $261.92 ISRG Intuitive Surgical $259.72 INTU Intuit $449.28 ROK Rockwell Automation $290.54 SMR NuScale Power $10.88 ASML (ASML) Source: Ralf Liebhold / Shutterstock The backstop of most semiconductor-related breakthrough technology stocks to buy, ASML (NASDAQ: ASML ) might not be a household name.
Residual disruption from the pandemic is lasting longer than expected.
Growth stocks have had a difficult time of it lately, but there looks to be a comeback brewing. After a tumultuous bear market in 2022, investors are eager for a more stable year. Moreover, it seems as though the equity market is rebounding, with many of the best growth stocks trading in the green. Though there is still considerable volatility in the market, there’s much to look forward to this year. There are still plenty of risks, such as supply chain hiccups, high-interest rates, and other macroeconomic factors. Those who have been patient enough to wait until now could reap healthy long-term rewards. The valuations of many of the top growth stocks have become particularly attractive following the selloff last year. Having said that, here are seven growth stocks with great potential for superior returns in 2023. AAPL Apple $145.93 ISRG Intuitive Surgical $247.26 CHPT ChargePoint $12.16 DDOG Datadog $77.23 U Unity Software $36.29 MARA Marathon Digital Holdings $8.02 PANW Palo Alto Networks $159.78 Apple ( AAPL ) Source: sylv1rob1 / Shutterstock.com Apple (NASDAQ: AAPL ) is arguably the most popular tech giant, which has made several strong moves across its various sectors.
The initial financial outlook Intuitive Surgical management gave for 2023 was something of a letdown given the stock''s high valuation.
Intuitive Surgical (NASDAQ: ISRG ) has outperformed the market over the past 10 years by 4.05% on an annualized basis producing an average annual return of 14.54%. Currently, Intuitive Surgical has a market capitalization of $87.68 billion. Buying $1000 In ISRG: If … Full story available on Benzinga.com
Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI ) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on Wednesday. Raymond James boosted the price target for Intuitive Surgical, Inc. (NASDAQ: ISRG ) from $255 to $270. Raymond James analyst Jayson Bedford maintained an Outperform rating. Intuitive Surgical shares fell 5.5% to close at $243.80 on Wednesday. Piper Sandler cut the price target for Aspen Technology, Inc. (NASDAQ: AZPN ) from $240 to $195. Piper Sandler analyst Clarke Jeffries maintained a Neutral rating on the stock. Aspen Technology shares fell 2% to close at $194.27 on Wednesday. UBS cut the price target for Pfizer Inc. (NYSE: Full story available on Benzinga.com
NEW YORK - Stocks that traded heavily or had substantial price changes Wednesday: Boeing Co., up 70 cents to $212.68. The aerospace-defense giant reported a big fourth-quarter…
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday: Boeing Co., up 70 cents to…
NDAQ and ISRG dropped following their respective earnings reports. SHOP rose on price increases. NWS advanced after a proposal was scrapped to re-merge with Fox.
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of $1.66 billion for the fourth quarter of 2022, which was up 7% year-over-year. GAAP net income attributable to Intuitive Surgical, Inc. was $325 million, or $0.91 per […] The post Intuitive Surgical (ISRG) Earnings: 4Q22 Key Numbers first appeared on AlphaStreet .
ISRG has seen its SMA50 which is now -8.43%. In looking the SMA 200 we see that the stock has seen a 4.55%. VBLT has seen its SMA50 which is … The post This stocks will boost Up Your investment: Intuitive Surgical, Inc. (NASDAQ:ISRG -6.00%), Vascular Biogenics Ltd. (NASDAQ:VBLT 1.91%) appeared first on Stocks Equity .
Intuitive Surgical earnings release and call disappoint analysts
https://www.investing.com/news/pro/intuitive-surgical-pt-raised-to-245-at-deutsche-bank-432SI-2987929
Intuitive Surgical Inc (NASDAQ: ISRG ) shares are down nearly 10% Wednesday morning after the company reported worse-than-expected financial results. Multiple analysts also cut price targets on the stock following Intuitive Surgical''s quarterly results . What Happened: Intuitive Surgical said fourth-quarter revenue increased 7% year-over-year to $1.66 billion, which missed average estimates of $1.67 billion, according to Benzinga Pro . The company reported quarterly earnings of $1.23 per share, which missed estimates of $1.25 per share. Worldwide da Vinci procedures jumped approximately 18% on a year-over-year basis despite a resurgence in COVID-19 in China, which negatively impacted procedure volumes in … Full story available on Benzinga.com
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Precigen, Inc. (NASDAQ: PGEN ) shares dipped 18.3% to $1.79 in pre-market trading after the company reported pricing of $75.0 million public offering of common stock. Intuitive Surgical, Inc. (NASDAQ: ISRG ) dropped 7.7% to $237.90 in pre-market after the company reported weaker-than-expected results for its fourth quarter on Tuesday. MicroCloud … Full story available on Benzinga.com
https://www.investing.com/news/pro/intuitive-surgical-pt-lowered-to-279-at-btig-432SI-2987541
https://www.investing.com/news/pro/intuitive-surgical-pt-lowered-to-285-at-stifel-432SI-2987407